FBR Remains Positive on Genocea Biosciences (GNCA) Following ATLAS Update; Affirms at 'Outperform'
Tweet Send to a Friend
FBR & Co. reaffirms Genocea Biosciences, Inc. (Nasdaq: GNCA) at Outperform with a price target of $17 after the presented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
